Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs lidocaine with epinephrine infiltration for cleft palate repair
ChiCTR2000029035Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine, lidocaine and epinephrine in cleft palate (2 arms), sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: FLACC score. Started Jan 2020; status: recruiting.
02
Drugs
ropivacainelidocaineepinephrine
03
Conditions
cleft palate
Beyond the preview
Go deeper on ChiCTR2000029035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029035.